Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic Lateral Sclerosis (LiCALS) [Eudract number: 2008-006891-31]

Ammar Al-Chalabi; Pamela J Shaw; Carolyn A Young; Karen E Morrison; Caroline Murphy; Marie Thornhill; Joanna Kelly; I Nicholas Steen; P Nigel Leigh; $author.firstName $author.lastName

doi:10.1186/1471-2377-11-111

Email this article to a friend

Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic Lateral Sclerosis (LiCALS) [Eudract number: 2008-006891-31]

Ammar Al-Chalabi^*, Pamela J Shaw, Carolyn A Young, Karen E Morrison, Caroline Murphy, Marie Thornhill, Joanna Kelly, I Nicholas Steen, P Nigel Leigh and on behalf of UKMND-LiCALS

* Corresponding author: Ammar Al-Chalabi ammar.al-chalabi@kcl.ac.uk

BMC Neurology 2011, 11:111 doi:10.1186/1471-2377-11-111

BMC Neurology

Viewing options

Associated material

Tools

Share this article

Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic Lateral Sclerosis (LiCALS) [Eudract number: 2008-006891-31]

BMC Neurology

Viewing options

Associated material

Related literature

Cited by

Other articles by authors

Related articles/pages

Tools

Share this article

Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic Lateral Sclerosis (LiCALS) [Eudract number: 2008-006891-31]